Kiriaki Paschoudi

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model.

CD117 epitope-shielded hematopoietic stem cell transplantation with toxin-free conditioning and in vivo selection ameliorates a β-thalassemia model.

Journal: bioRxiv : the preprint server for biology

Published: July 17, 2026

Epigenetic Regulation of Erythropoiesis: From Developmental Programs to Therapeutic Targets.

Epigenetic Regulation of Erythropoiesis: From Developmental Programs to Therapeutic Targets.

Journal: International journal of molecular sciences

Published: May 02, 2025

Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice.

Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 14, 2024

Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors.

Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors.

Journal: Nature communications

Published: November 28, 2023

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.

Journal: International journal of molecular sciences

Published: April 21, 2023

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.

Journal: Genes

Published: September 16, 2022

In vivo HSC prime editing rescues sickle cell disease in a mouse model.

In vivo HSC prime editing rescues sickle cell disease in a mouse model.

Journal: Blood

Published: August 29, 2022

In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.

In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.

Journal: JCI insight

Published: June 22, 2022

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot.

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot.

Journal: Heliyon

Published: January 07, 2022

Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.

Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.

Journal: Blood

Published: November 20, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026